The global non-small cell lung carcinoma market is poised for significant expansion over the next decade, according to new industry projections. Valued at USD 8.25 billion in 2023, the NSCLC market is ...

So far, SpringWorks – which was spun out of Pfizer in 2017 and has recently received FDA approval for a second therapy for a ...

Transgene Provides Business and Financial Update for Q1 2025  TG4050: Updated randomized Phase I data to be presented in Rapid Oral Presentation at ASCO 2025Dr. Simone Steiner appointed Chief ...

The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

The efficacy and safety of the dual immunotherapy were studied in the CheckMate 8HW trial. This phase 3, randomised, open-label, international study enrolled 128 immunotherapy-naive adults at 128 ...

Allergy shots are a common type of allergy immunotherapy, used to reduce your immune system’s reaction to an allergen by building long-term tolerance through gradual exposure. A healthcare provider ...

A medication class is a group of drugs that work in a similar way. PD-1 inhibitors are a type of immunotherapy for cancer. Opdivo and Keytruda may be used alone or in combination with other drugs ...

Neoadjuvant immunotherapy has emerged as a promising ... NJ, USA. BAVENCIO /avelumab is provided by Merck KGaA, Darmstadt, Germany, previously as part of an alliance between the healthcare ...

1Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands. *Corresponding Author: Gerrit Jan Liefers, Department of Surgery, Leiden University Medical Center, Albinusdreef 2, ...

Neoadjuvant combination immunotherapy regimens produced higher pathologic response rates than monotherapy in a trial for HNSCC. Results showed an association between pathologic response and survival.